UK markets open in 2 hours 15 minutes

Ekso Bionics Holdings, Inc. (0IFR.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
1.1980-0.1127 (-8.60%)
At close: 02:31PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.64
52-week change 313.60%
S&P500 52-week change 322.64%
52-week high 33.1000
52-week low 30.0000
50-day moving average 31.9276
200-day moving average 31.6103

Share statistics

Avg vol (3-month) 31.15k
Avg vol (10-day) 31.16k
Shares outstanding 562.64M
Implied shares outstanding 6N/A
Float 816.01M
% held by insiders 113.50%
% held by institutions 17.61%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.066667:1
Last split date 325 Mar 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -83.14%
Operating margin (ttm)-71.16%

Management effectiveness

Return on assets (ttm)-27.06%
Return on equity (ttm)-79.89%

Income statement

Revenue (ttm)18.28M
Revenue per share (ttm)1.32
Quarterly revenue growth (yoy)36.50%
Gross profit (ttm)N/A
EBITDA -13.41M
Net income avi to common (ttm)-15.2M
Diluted EPS (ttm)-0.9260
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.64M
Total cash per share (mrq)0.48
Total debt (mrq)7.17M
Total debt/equity (mrq)56.86%
Current ratio (mrq)2.49
Book value per share (mrq)0.85

Cash flow statement

Operating cash flow (ttm)-12.05M
Levered free cash flow (ttm)-6.96M